Jonathan Rubin insider trades
Open-market stock purchases and sales by Jonathan Rubin, SVP, Chief Medical Officer at Supernus Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 19, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 12, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | $16.9K |
| Aug 12, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Jul 29, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 25, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 25, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | $34.2K |
| Feb 25, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | $31K |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | $18.8K |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | — |
| Feb 18, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 18, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- SUPN Supernus Pharmaceuticals, Inc: 1 sale, last Aug 12, 2026